alexa Inflammatory bowel disease | France| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Inflammatory Bowel Disease

  • Inflammatory bowel disease

    Inflammatory bowel disease (IBD) involves chronic inflammation of all or part of your digestive tract. IBD primarily includes ulcerative colitis and Crohn's disease.Severe diarrhea, pain, fatigue and weight loss. IBD can be debilitating and sometimes leads to life-threatening complications.
    Doctors use one of two approaches to treatment: "step-up," which starts with milder drugs first, versus "top-down," which gives people stronger drugs earlier in the treatment process.

  • Inflammatory bowel disease

    117 patients with IBD (exclusion of postoperative pat. (up to 1 month) and pat. with abscesses. 70.1% receiving pain medications at admission (median 12 mg in first 24 hours, median daily later on 7.5 mg/day.7.7 % PCA pump.More common than Crohn’s Incidence: 10 per 100,000 Prevalence 240 per 100,000 in the UK Age of onset: 2 peaks 1).

  • Inflammatory bowel disease

    Inflammatory bowel disease (IBD) is an idiopathic disease caused by a dysregulated immune response to host intestinal microflora. The two major types of inflammatory bowel disease are ulcerative colitis (UC), which is limited to the colon, and Crohn disease (CD), which can affect any segment of the gastrointestinal tract from the mouth to the anus, involves "skip lesions," and is transmural. There is a genetic predisposition for IBD, and patients with this condition are more prone to the development of malignancy.

Expert PPTs
Speaker PPTs

High Impact List of Articles

Conference Proceedings